Nice commentary on $TMDX — so many exciting catalysts on the horizon that could/should re-accelerate YoY growth back above 30% which is definitely not priced in with $TMDX in the $70s. The stock is on sale because of short term margin compression… because management decided it was more important to invest for the next decade than worry about the next few quarterly EPS numbers. Management is making the right decisions for patients and long term shareholders. I believe that 100%. I just wish they had been more transparent the past couple quarters with their spending levels. Stock would not have gotten hammered if we had known the hit that net income margins was going to take and how long the margin compression would last. $TMDX has a very loyal and passionate shareholder base… we have
View on X ↗